Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

IPSC Stock Annual Income Statement. Download in Excel

Century Therapeutics Inc logo

Century Therapeutics Inc

Sector: Professional, Scientific, and Technical Services   

Industry: Research and Development in Biotechnology

1.10
 
USD
  
0.05
  
(4.76%)
Previous close: 1.05  Open: 1.05  Bid: 1.05  Ask: 1.15
52 week range    
0.98   
   5.51
Mkt Cap: 99 M  Avg Vol (90 Days): 538,966
Peers   
OTIC / 
OTLC / 
OVAT-CA / 
Last updated: Monday 23rd December 2024

Stock Rankings

38
MarketXLS Rank
60
Value
30
Technical
26
Quality
How are these ranks calculated?
Search for a stock

Financials

IPSC Income Statement

Annual
Invalid dateDec-21Dec-22Dec-23
Basic EPS from continuing operations-2.96-2.27-2.3
Basic EPS total-2.96-2.27-2.3
Basic weighted shares outstanding32 M58 M59 M
Depreciation4 M8 M13 M
DepreciationAndAmortization4 M8 M13 M
Diluted EPS total-2.96-2.27-2.3
Diluted normalized net income/share-2.96-2.27-2.27
Diluted weighted shares outstanding32 M58 M58 M
GeneralAndAdministrativeExpense19 M32 M35 M
Gross operating profit5 M2 M
ImpairmentOfCapitalAssets16 M
Income before tax-96 M-131 M-135 M
Income taxes43000.091000.02 M
InterestExpenseNonOperating1 M1 M540000.0
MiscOtherSpecialCharges-898000.03 M12 M
Net income from total operations-96 M-131 M-137 M
NetIncomeCommonStockholders-96 M-121 M-137 M
NetIncomeContinuousOperations-96 M-131 M-137 M
NetNonOperatingInterestIncomeExpense-1 M-3 M-540000.0
Normalized income-76 M
Operating income-95 M-134 M-147 M
Operating income before depreciation (EBITDA)-90 M-121 M-121 M
OperatingExpense95 M129 M149 M
Other income net898000.0-10 M-12 M
OtherGandA19 M32 M35 M
OtherImpairmentOfCapitalAssets11 M
OtherOperatingExpenses6 M9 M8 M
Research & development expense76 M97 M93 M
ResearchExpense76 M97 M93 M
Revenue per share306000.0299000.094000.0
Selling Gen & administrative expense19 M32 M35 M
Special income/charges-16 M
Total Income available for interest expense (EBIT)-95 M-130 M-134 M
Total common shares outstanding59 M59 M65 M
Total net income-96 M-131 M-137 M
Total ordinary shares85 M85 M85 M
Total revenues5 M2 M
TotalExpenses95 M129 M149 M
TotalRevenue5 M2 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University